In March 2019, UPMC broke ground on the new UPMC Vision and Rehabilitation Tower at UPMC Mercy in Pittsburgh's Uptown. Clinicians and researchers at the new hospital will pursue innovative research for vision restoration and diseases of the eye and offer technology-assisted rehabilitation services that restore mobility for patients with physical and cognitive challenges.
Meanwhile, through investments aimed at breakthrough treatments and cures for a wide variety of diseases, UPMC Enterprises announced that it will deploy $1 billion to develop new drugs, diagnostics and devices by 2024. With offices in Bakery Square, UPMC Enterprises is seeking investments and partners globally that complement scientific and commercial work already underway in Pittsburgh.
Answering the Call in Times of Crisis
UPMC is keeping patients and providers safe during the COVID-19 pandemic, ramping up telehealth efforts, training and redeploying thousands of employees to treat patients through virtual visits.
In April 2020, UPMC and University of Pittsburgh School of Medicine scientists announced research into a potential vaccine, delivered through a fingertip-sized patch. Researchers are using existing groundwork laid during earlier coronavirus epidemics. The rapid work on this vaccine is the result of scientists with diverse expertise working together in the region's hub of health care innovation.
To help care for the communities UPMC serves, the Beckwith Institute provided $200,000 to address food insecurity and other emergency needs for the most vulnerable people in communities across Pennsylvania, western Maryland, and western New York.